1. Home
  2. EFR vs PBYI Comparison

EFR vs PBYI Comparison

Compare EFR & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

EFR

Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

HOLD

Current Price

$11.07

Market Cap

327.1M

Sector

Finance

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.94

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFR
PBYI
Founded
2003
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.1M
263.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EFR
PBYI
Price
$11.07
$5.94
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
88.6K
396.2K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
9.43%
N/A
EPS Growth
N/A
59.87
EPS
1.69
0.74
Revenue
N/A
$211,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.74
$7.83
Revenue Growth
N/A
N/A
52 Week Low
$10.95
$2.58
52 Week High
$13.29
$6.12

Technical Indicators

Market Signals
Indicator
EFR
PBYI
Relative Strength Index (RSI) 41.94 65.69
Support Level $11.14 $5.51
Resistance Level $11.24 $5.73
Average True Range (ATR) 0.07 0.22
MACD -0.01 0.03
Stochastic Oscillator 26.09 94.70

Price Performance

Historical Comparison
EFR
PBYI

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: